Literature DB >> 10903189

Macroangiopathy of the upper extremities in progressive systemic sclerosis.

M Stücker1, S Quinna, U Memmel, A Röchling, M Traupe, K Hoffmann, O Köster, P Altmeyer.   

Abstract

BACKGROUND: Raynaud's phenomenon is a hallmark of progressive systemic sclerosis (SSc). While nailfold capillary changes are well known, morphological changes in larger arteries have less been focused on. OBJECTIVE AND METHODS: In the study presented we examined how often in digital subtraction angiography organic changes of the arteries of the fingers, hands and forearms were observed, whether they showed a typical picture like the changes in nailfold capillaries and whether they correlated with cutaneous sclerosis, Raynaud's phenomenon and serological findings. 29 patients were examined, 14 with acroscleroderma and 15 with proximal ascending sclerosis.
RESULTS: In 27 of those 29 patients a stenosis of the arteries of the upper extremity was found. The frequency of arterial occlusions decreased from the fingers (26 patients) to the forearms (9 patients with occlusion of the ulnar artery, none with occlusion of the radial artery). The arteries of 47% of patients with proximal ascending sclerosis showed no reactivity towards the alpha-sympatholyticum tolazoline hydrochloride due to severe organic changes while in patients with acroscleroderma only 14% of patients did not respond to tolazoline hydrochloride. The severity of Raynaud's phenomenon did not correlate with the severity of the angiographic findings. In patients with stenoses refractory to tolazoline hydrochloride and in those with occlusions Scl-70 autoantibodies were more frequently positive than in other patients with SSc (44% compared to 23%).
CONCLUSION: As in SSc the severity of the organic arterial changes is in close correlation with the extent of the cutaneous sclerosis and with the serological findings the arterial system should gain much more importance in the diagnosis and therapy of SSc.

Entities:  

Mesh:

Year:  2000        PMID: 10903189

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  6 in total

1.  The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function.

Authors:  Alma Cypiene; Aleksandras Laucevicius; Algirdas Venalis; Jolanta Dadoniene; Ligita Ryliskyte; Zaneta Petrulioniene; Milda Kovaite; Jonas Gintautas
Journal:  Clin Rheumatol       Date:  2008-07-25       Impact factor: 2.980

Review 2.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 3.  Imaging features of musculoskeletal involvement in systemic sclerosis.

Authors:  Nathalie Boutry; Eric Hachulla; Claire Zanetti-Musielak; Mélanie Morel; Xavier Demondion; Anne Cotten
Journal:  Eur Radiol       Date:  2006-09-23       Impact factor: 5.315

Review 4.  Ulnar artery vasculopathy in systemic sclerosis.

Authors:  Jeong Ha Park; Yoon-Kyoung Sung; Sang-Cheol Bae; Soon-Young Song; Heong Seok Seo; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2009-04-12       Impact factor: 2.631

Review 5.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

6.  No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.

Authors:  Martha E Hettema; Dan Zhang; Ymkje Stienstra; Andries J Smit; Hendrika Bootsma; Cees G M Kallenberg
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.